Item(by='Exmoor', descendants=None, kids=None, score=None, time=1607641813, title=None, item_type='comment', url=None, parent=25380009, text='&gt; The committee voted 17-4 in favor that the known benefits of the vaccine,<p>I watched most of the discussion. There was a lot of discussion (I would, perhaps call it woodshedding) about the whether 16 and 17 year olds should be included. Not because it&#x27;s not safe for them, but because they&#x27;re far less likely to be as negatively impacted by the disease as older age groups and therefore the very small risk is more meaningful. I think that&#x27;s where some of the 4 no votes came from.<p>Final step should come soon:<p>&gt; Following the advisory committee meeting, FDAâ€™s career professional staff will consider the input of the advisory committee members and continue their evaluation of the submission to determine whether the available safety and effectiveness and manufacturing data support an emergency use authorization of the specific COVID-19 vaccine in the United States.<p><a href="https:&#x2F;&#x2F;www.fda.gov&#x2F;vaccines-blood-biologics&#x2F;vaccines&#x2F;emergency-use-authorization-vaccines-explained" rel="nofollow">https:&#x2F;&#x2F;www.fda.gov&#x2F;vaccines-blood-biologics&#x2F;vaccines&#x2F;emerge...</a>')